Академический Документы
Профессиональный Документы
Культура Документы
Independent T test:
Mustard fomentation groups at presentations. There was a not a significant difference in the
1
suggest that intraarticular steroids treatment and Mustard fomentation did not differ in
presentation.
2) At 15 days follow up
Group Statistics
Mustard fomentation Groups at 15 days follow up of treatment. There was not a significant
2
Mustard fomentation (M=73.07, SD=6.9) conditions; t(58)= .5, p =..552. These results
suggest that intraarticular steroids treatment and Mustard fomentation do not differ in their
at 15 days of follow up
3) At 45 days follow up
Group Statistics
3
difference in the scores for WOMAC (WESTERN ONTARIO AND MCMASTER
Mustard fomentation (M=72.97, SD=6.8) conditions; t(58)= 1.3, p =.174. These results
suggest that intraarticular steroids treatment and Mustard fomentation do not differ in their
4) At 3 months follow up
Group Statistics
4
fomentation Groups at 3 months of follow up of treatment. There was a significant difference
and Mustard fomentation (M=72.70, SD=6.64) conditions; t(58)= 2.67, p =.01. These results
suggest that intraarticular steroids treatment and Mustard fomentation differ in their effect
5) At 6 months follow up
Group Statistics
5
Independent-samples t-test was conducted to compare WOMAC (WESTERN ONTARIO
(M=81.73, SD=7.497 and Mustard fomentation (M= 71.33 , SD= 7.54 ) conditions; t(58)=
5.356, p =.000. These results suggest that intraarticular corticosteroids treatment and Mustard
1) Baseline
Group Statistics
6
Equal -
variances .117 .734 .93 58 .352 -.233 .249 -.731 .264
vas(mm)
assumed 9
at base
Equal - 56.
line
variances .93 69 .352 -.233 .249 -.731 .265
not assumed 9 2
An independent-samples t-test was conducted to compare VAS score in intraarticular steroids
and Mustard fomentation groups at baseline presentations. There was not a significant
difference in VAS score at baseline in Intraarticular steroids Group (M= 6.97, SD=1.03 and
Mustard fomentation group (M=7.2, SD=.887) conditions; t (58) = -.939, p =.352. These
results suggest that intraarticular steroids and Mustard fomentation groups did not differ in
2) At 15 days follow up
Group Statistics
7
Equal - 57.
variances not 1.3 98 .193 -.433 .329 -1.091 .225
assumed 18 1
steroids and Mustard fomentation Groups at 15 days follow up of treatment. There was not a
Mustard fomentation Groups (M=6.27, SD=1.285) conditions; t (58) = 1.3, p =.193. These
results suggest that intraarticular steroids and Mustard fomentation groups do not differ in
3) At 45 days follow up
Group Statistics
8
Equal 56.
.40
variances 96 .690 .100 .249 -.399 .599
1
not assumed 0
significant difference in the scores for VAS score in Intraarticular steroids (M=5.43, SD=.89
and Mustard fomentation (M=5.33, SD=1.02) conditions; t (58) = 0.4, p =.690. These results
suggest that intraarticular steroids treatment and Mustard fomentation application do not
4) At 3 months follow up
Group Statistics
9
Independent-samples t-test was conducted to compare VAS score in
treatment. There was a significant difference in the scores for VAS score at 3
results suggest that intraarticular steroids treatment and Mustard fomentation differ
in their effect on VAS score at 3 months of follow up. Mustard Fomentation found
5) At 6 months follow up
Group Statistics
10
Independent-samples t-test was conducted to compare VAS score in intraarticular steroids
t(58)= 4.933, p =.000. These results suggest that intraarticular steroids treatment and Mustard
fomentation differ in their effect on VAS score at 6 months of follow up. Mustard
Fomentation significantly reduced VAS score than that in intraarticular steroids treatment.
WOMAC
83.6333 30 6.99992 1.27800
BASE LINE
WOMAC 15
71.8333 30 8.89046 1.62317
DAYS
11
A paired-samples t-test was conducted to compare WOMAC Scores at baseline and 15
days of follow up of intraarticular steroids. There was a significant difference in the scores
for WOMAC at baseline (M=83.63, SD=6.99) and WOMAC at 15 days follow up (M=71.83,
SD=8.89) conditions; t (29) =-7.52, p = 0.001. These results suggest that WOMAC reduced
2) At 45 days
WOMAC BASE
83.6333 30 6.99992 1.27800
LINE
WOMAC 45
75.5667 30 7.77123 1.41883
DAYS
days of follow up of treatment with intraarticular steroids. There was a significant difference
in the scores for WOMAC at baseline (M=83.63, SD=6.99) and WOMAC at 45 days follow
up (M=75.56, SD=7.77) conditions; t (29) =-5.96, p = 0.001. These results suggest that
WOMAC reduced after 45 days of treatment but it is more compared to 15 days follow up
3) At 3 months
12
Paired Samples Statistic
WOMAC BASE
83.6333 30 6.99992 1.27800
LINE
WOMAC 3
77.6000 30 7.49529 1.36845
MONTHS
difference in the scores for WOMAC at baseline (M=83.63, SD=6.99) and WOMAC at 3
months follow up (M=77.60, SD=7.49) conditions; t (29) =-5.00, p = 0.001. These results
suggest that WOMAC reduced after 3 months of treatment but it is more compared to 15 days
and 45 days follow up suggesting that effect of intra articular steroids is further waning off.
4) At 6 months
WOMAC BASE
83.6333 30 6.99992 1.27800
LINE
WOMAC 6
81.7333 30 7.49682 1.36873
MONTHS
13
Paired Samples Test
Paired Differences t df Sig. (2-
Mean Std. Std. Error 95% Confidence tailed)
Deviation Mean Interval of the
Difference
Lower Upper
WOMAC BASE
Pair LINE - 1.900
4.25360 .77660 .31168 3.48832 2.447 29 .021
4 WOMAC 6 00
MONTHS
difference in the scores for WOMAC at baseline (M=83.63, SD=6.99) and WOMAC at 6
months of follow up (M=81.73, SD=7.49) conditions; t (29) =-2.44, p = 0.021. These results
suggest that WOMAC reduced after 6 months of treatment but it is more compared to 15
days, 45 days and 3 months of follow up period suggesting that effect of intra articular
2) VAS
1) At 15 days
14
A paired-samples t-test was conducted to compare VAS Scores at baseline and 15 days of
follow up of intraarticular steroids. There was a significant difference in the scores for VAS
conditions; t (29) =-7.57, p = 0.001. These results suggest that VAS reduced significantly
2) At 45 days
A paired-samples t-test was conducted to compare VAS Scores at baseline and 45 days of
follow up of intraarticular steroids. There was a significant difference in the scores for VAS
conditions; t (29) =-10.25, p = 0.001. These results suggest that VAS reduced significantly
after 15 days of treatment with intra articular steroids and further reduced compared to 15
15
3) At 3 Months
A paired-samples t-test was conducted to compare VAS Scores at baseline and 3 months
of follow up of intraarticular steroids. There was a significant difference in the scores for
VAS at baseline (M=6.96, SD=1.03) and VAS at 3 months follow up (M=5.36, SD=1.27)
conditions; t (29) =-7.02, p = 0.001. These results suggest that not only VAS reduced
significantly after 3 months of treatment with intra articular steroids but also reduced further
4) At 6 Months
16
Mean Std. Std. Error 95% Confidence Interval tailed)
Deviation Mean of the Difference
Lower Upper
VAS BASE LINE - VAS 6 1.2000
1.42393 .25997 .66829 1.73171 4.616 29 .000
MONTHS 0
Paired-samples t-test was conducted to compare VAS Scores at baseline and 6 months of
follow up of intraarticular steroids. There was a significant difference in the scores for VAS
conditions; t (29) =-4.61, p = 0.001. These results suggest that VAS with intra articular
steroids treatment reduced marginally after 6 months of treatment compared to baseline but
also increased further compared to 45 days follow up suggesting waning of effect of steroids
on patients symptoms.
WOMAC
1) At 15 days
17
A paired-samples t-test was conducted to compare WOMAC Scores at baseline and 15
days of follow up of mustard fomentation. There was a significant difference in the scores for
SD=6.94) conditions; t (29) =-17.31, p = 0.001. These results suggest that WOMAC reduced
2) At 45 days
days of follow up of mustard fomentation. There was a significant difference in the scores for
SD=6.82) conditions; t (29) =-17.61, p = 0.001. These results suggest that WOMAC reduced
3) At 3 Months
18
Paired Differences t df Sig. (2-
Mean Std. Std. Error 95% Confidence tailed)
Deviation Mean Interval of the
Difference
Lower Upper
WOMAC BASE LINE - 12.866 23.03
3.05956 .55860 11.72421 14.00913 29 .000
WOMAC 3 MONTHS 67 4
months of follow up of mustard fomentation. There was a significant difference in the scores
for WOMAC at baseline (M=85.56, SD=5.31) and WOMAC at 3 months follow up (M=72.7,
SD=6.64) conditions; t (29) =-23.03, p = 0.001. These results suggest that WOMAC reduced
significantly after 3 months of treatment with mustard fomentation compared to baseline and
4) At 6 Months
Pair 4
14.233 18.78
WOMAC BASE LINE - 4.14964 .75762 12.68383 15.78284 29 .000
33 7
WOMAC 6 MONTHS
Paired-samples t-test was conducted to compare WOMAC Scores at baseline and 6
months of follow up of mustard fomentation. There was a significant difference in the scores
19
for WOMAC at baseline (M=85.56, SD=5.31) and WOMAC at 6 months follow up (M=72.3,
SD=7.54) conditions; t (29) =-18.78, p = 0.001. These results suggest that WOMAC reduced
VAS
1) At 15 days
follow up of mustard fomentation. There was a significant difference in the scores for VAS at
baseline (M=7.2, SD=0.88) and VAS at 15 days follow up (M=6.26, SD=1.28) conditions; t
(29) =-6.1, p = 0.001. These results suggest that VAS reduced significantly after 15 days of
2) At 45 days
20
Paired Samples Test
days of follow up of mustard fomentation. There was a significant difference in the scores for
VAS at baseline (M=7.2, SD=0.88) and VAS at 45 days follow up (M=5.33, SD=1.02)
conditions; t (29) =-13.17, p = 0.001. These results suggest that VAS reduced significantly
3) At 3 Months
months of follow up of mustard fomentation. There was a significant difference in the scores
for VAS at baseline (M=7.2, SD=0.88) and VAS at 3 months follow up (M=4.73, SD=1.22)
21
conditions; t (29) =-13.88, p = 0.001. These results suggest that VAS reduced significantly
after 3 months of treatment with mustard fomentation compared not only to baseline but also
4) At 6 Months
Paired-samples t-test was conducted to compare VAS Scores at baseline and 6 months
of follow up of mustard fomentation. There was a significant difference in the scores for VAS
conditions; t (29) =-13.88, p = 0.001. These results suggest that VAS reduced significantly
after 6 months of treatment with mustard fomentation compared not only to baseline and 45
days follow up but also when compared to 3 months follow up indicating progressive long
Complications:
In Group 1 (Intra articular steroid group) 4 patients (13.3%) cases had few complications.
Case no 5 and 23 had infection following steroid injection which required further active
22
interventions like antibiotics and dressings. Eventually infection settled within 6 weeks but
patients were left with more pain due to septic destruction of cartilage. Case no 18 had
vasovagal syncope following injection had to be managed by fluids and limb elevation. Case
25 had subcutaneous lipoatrophy by the end of 6 months follow up which was asymptomatic
but cosmetically disagreeable forming another source of patients discomfort. There were no
DISCUSSION:
Osteoarthritis is not just mechanical problem but it is mediated through various inflammatory
mediators too. Both steroids and mustard target this part of pathology and provide relief to
epidemiological studies have defined osteoarthritis in this scale (Osteoarthritis. Paul Creamer
Marc Hochberg;The Lancet Vol 350, Aug 1997:503-508) and as the next stage is not
amenable for conservative treatment. In the present study steroids show progressive
improvement in patients clinical condition in the initial period but after 3 months the effects
starts falling and by 6 months the WOMAC score falls almost equal the baseline score ,
emphasizing that the good effect of steroids lasts not very long and this correlates well with
A Randomized Clinical Trial Neil Bodick, MD, PhD, Joelle Lufkin, Christina Willwerth, Anjali Kumar,
Chris Schoonmaker, PhD, Rahul Ballal, PhD, David Hunter, MD, and Michael Clay, J Bone Joint Surg Am.
a systematic review of level I studies, Journal of the American Academy of Orthopaedic Surgeons, vol. 17, no. 10, pp. 638
23
646,
1980.) The likely site of action of intra-articular corticosteroids in the osteoarthritic joint is the
inflamed synovium. Synovitis has been demonstrated with both histology and imaging
disease. The symptom free interval provided by steroids can be regarded as due to
suppression of this ongoing synovitis and hence may not last long.( Scanzello CR, Goldring SR. The
role of synovitis in osteoarthritis pathogenesis. Bone. 2012 Aug;51(2):249-57.)( Benito MJ, Veale DJ, FitzGerald O,
Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263-126
with radiographic severity of knee osteoarthritis. Arthritis Rheum 2011; 63: 2983-2991 )
Steroids are associated with complications like superficial infection and subcutaneous
atrophy in four patients in this study. The clinical outcome in this group was compounded by
additional disease burden due to complications and treatment measures on these patients.
Even though sterile precautions were taken while steroid injection, patients local skin
condition, systemic immunosuppression due to diabetes and other diseases may have
subcutaneous lipoatrophy to failure of drug delivery deep into the joint or seepage of drug
into subcutaneous planes The instances of dizziness, syncope, haemorrhage, and local
discomfort are probably not dissimilar from other injections performed in the surgery;
24
.( Complications of intra- and peri-articular steroid injections Naresh Kumar
progressive improvement in patients clinical condition from baseline to 6 months follow up.
The WOMAC and VAS scores in the present study are statistically significant both within the
group and when compared to steroid group. Though literature on mustard fomentation is
scanty to compare this study, we observe the nociceptive and counter irritant properties of
mustard in any form are effective enough to relieve the main symptom of osteoarthritis i.e.,
pain.( Acupuncture -A Problem for the Anesthetist ? .Sampson Lipton FFA RCS Proc. roy.
Consistent increase in the patients functional profile with mustard fomentation can
fomentation on a regular basis. The absence of any complications in this group is further
Limitations of Study:
2) Both WOMAC and VAS are subjective and depend on patients understanding and
25
Conclusion:
Intra articular steroids and mustard fomentation are effective means of treating cases
patient compliance and moreover longer lasting pain relief, we conclude that Mustard
Summary:
This was a prospective study of evaluating effectiveness of intra articular steroids and
mustard fomentation on osteoarthritis of knee and comparing them with each other. 60
patients were enrolled and randomly allocated to two groups. Each group received the
respective treatment modalities as per standards laid down. Steroid group had initial good
relief and failed to sustain the same for 6 months and associated with few complications but
mustard group achieved the good relief of symptoms which lasted even after 6 months.
Considering the long lasting good relief and no complications study concluded mustard
fomentation to be superior to steroids even though both of them cannot alter the disease
26
Abstract:
Materials and Methods: One knee of 60 patients, both males and females was
included in the study. 30 Patients were randomly included in each of two groups. i.e., steroid
group and mustard group. Patients were followed up at 15 days, 45 days , 3 months and 6
months. They were assessed at each follow up with WOMAC and VAS scoring and SPSS
version 20 for windows software was used for analysing the results.
Results: Group I showed progressive decrease in the WOMAC and VAS scores at 15
days, 45 days. But WOMAC started increasing to baseline levels at 3 months and 6 months
follow up. Few compliations reported. Group II showed consistent decrease in these scores in
all the follow up periods and there was long lasting relief. No complications reported.
Conclusion: In terms of significant sustained and long lasting relief in group II and
27